Does PAMIDRONATE Cause Interstitial lung disease? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Interstitial lung disease have been filed in association with PAMIDRONATE (Pamidronate Disodium). This represents 1.5% of all adverse event reports for PAMIDRONATE.
25
Reports of Interstitial lung disease with PAMIDRONATE
1.5%
of all PAMIDRONATE reports
3
Deaths
5
Hospitalizations
How Dangerous Is Interstitial lung disease From PAMIDRONATE?
Of the 25 reports, 3 (12.0%) resulted in death, 5 (20.0%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for PAMIDRONATE.
What Other Side Effects Does PAMIDRONATE Cause?
Osteonecrosis of jaw (313)
Drug ineffective (180)
Pain (164)
Off label use (143)
Pyrexia (106)
Malignant neoplasm progression (103)
Dyspnoea (102)
Fatigue (97)
Pain in jaw (97)
Metastases to bone (95)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which PAMIDRONATE Alternatives Have Lower Interstitial lung disease Risk?
PAMIDRONATE vs PAMIDRONIC ACID
PAMIDRONATE vs PANCRELIPASE
PAMIDRONATE vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE
PAMIDRONATE vs PANCURONIUM
PAMIDRONATE vs PANITUMUMAB